Main page content

Displaying results 1 - 7 of 7
Publication ID: PEP20-06-02-001
Published:

This guide reviews interventions on treating substance misuse and substance use disorders (SUD) in youth with serious emotional disturbances (SED), distills the research into recommendations for practice, and provides examples of the ways that these recommendations can be implemented.

Publication ID: PEP20-06-01-001
Published:

This guide supports health care providers, systems, and communities seeking to treat stimulant use disorders. It describes relevant research findings, examines best practices, identifies knowledge gaps and implementation challenges, and offers useful resources.

Publication ID: SMA17-5029
Published:

This report highlights the structure, responsibilities, policies, services, and financing of single-state agencies and state mental health agencies. The report includes discussion of efforts to integrate physical and behavioral health and efforts by state agencies to address opioid abuse and misuse.

Publication ID: SMA14-4842
Published:

This report discusses a technical expert panel convened to assess research about therapeutic services for youth living in foster care. It reviews the scientific evidence and expert panel input to identify action items and further research needs.

Publication ID: SMA13-4765SPAN
Published:

Proporciona herramientas para ayudar a organizar un día para el diálogo comunitario acerca de la salud mental. Habla sobre la logística de encontrar un lugar, formar una red de socios; reclutar participantes y facilitadores, organizar la reunión e identificar las medidas de seguimiento. Nota: Habrá copias impresas de este documento disponibles en el futuro cercano.

Publication ID: SMA12-4682
Published:

This advisory gives an overview of extended-release injectable naltrexone for people with opioid dependence. It discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit.

Publication ID: SMA10-4554
Published:

This advisory defines protracted withdrawal and identifies specific withdrawal symptoms associated with alcohol, opioids, methamphetamine, cocaine, marijuana, and benzodiazepines. The advisory also explains how protracted withdrawal differs from acute withdrawal, and gives tips to help clients manage it in recovery.